A Case of Hyperinsulinemic Hypoglycemia Related with a Calcimimetic Agent

Overview

Journal Diabetol Int

Specialty Endocrinology

Date 2019 Jan 4

PMID 30603367

Authors

Satoru Takashima

Takuma Narita

Hitomi Otomo

Tatsunori Shimizu

Yuichiro Yamada

Affiliations

Soon will be listed here.

Abstract

We herein report a case of a 60-year-old female receiving hemodialysis who developed severe hyperinsulinemic hypoglycemia and lost her consciousness. A calcimimetic agent had been administered for the secondary hyperparathyroidism. The calcimimetic agent, mimicking the elevation of the extracellular calcium ion concentration, activates calcium-sensing receptors (CaSR) of the parathyroid cells and inhibits the parathyroid hormone secretions. The previous study suggested that the CaSR are also expressed in both human β cells and insulinoma cells, but the reactivity to change in the extracellular calcium ion concentration is different between normal β cells and insulinoma cells. After cessation of the calcimimetic agent, hypoglycemic symptoms disappeared and endogenous insulin secretion dropped to normal levels. However, the result of a prolonged fasting test indicated that she remained hyperinsulinemic even after its cessation, suggesting that she had insulinoma which could not be detected by the imaging examinations. The previous autopsy data showed that there were many cases of the insulinoma without the symptoms of hypoglycemia. We considered the possibility that she had the insulinoma and the pancreatic tumor was too small to promote the insulin secretion and cause hypoglycemia without activation by the calcimimetic agent. We should know that the calcimimetic agent could cause hyperinsulinemic hypoglycemia with the unidentified insulinoma.

References

Marks V, Teale J . Drug-induced hypoglycemia. Endocrinol Metab Clin North Am. 1999; 28(3):555-77. DOI: 10.1016/s0889-8529(05)70088-8. View

Squires P . Non-Ca2+-homeostatic functions of the extracellular Ca2+-sensing receptor (CaR) in endocrine tissues. J Endocrinol. 2000; 165(2):173-7. DOI: 10.1677/joe.0.1650173. View

Racz G, Kittel A, Riccardi D, Case R, Elliott A, Varga G . Extracellular calcium sensing receptor in human pancreatic cells. Gut. 2002; 51(5):705-11. PMC: 1773426. DOI: 10.1136/gut.51.5.705. View

Komoto I, Kato M, Itami A, Shimada Y, Doi R, Hosotani R . Expression and function of the calcium-sensing receptor in pancreatic islets and insulinoma cells. Pancreas. 2003; 26(2):178-84. DOI: 10.1097/00006676-200303000-00015. View

Nemeth E, Heaton W, Miller M, Fox J, Balandrin M, Van Wagenen B . Pharmacodynamics of the type II calcimimetic compound cinacalcet HCl. J Pharmacol Exp Ther. 2003; 308(2):627-35. DOI: 10.1124/jpet.103.057273. View

Block G, Martin K, de Francisco A, Turner S, Avram M, Suranyi M . Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med. 2004; 350(15):1516-25. DOI: 10.1056/NEJMoa031633. View

Noone T, Hosey J, Firat Z, Semelka R . Imaging and localization of islet-cell tumours of the pancreas on CT and MRI. Best Pract Res Clin Endocrinol Metab. 2005; 19(2):195-211. DOI: 10.1016/j.beem.2004.11.013. View

Gray E, Muller D, Squires P, Asare-Anane H, Huang G, Amiel S . Activation of the extracellular calcium-sensing receptor initiates insulin secretion from human islets of Langerhans: involvement of protein kinases. J Endocrinol. 2006; 190(3):703-10. DOI: 10.1677/joe.1.06891. View

Ito T, Tanaka M, Sasano H, Osamura Y, Sasaki I, Kimura W . Preliminary results of a Japanese nationwide survey of neuroendocrine gastrointestinal tumors. J Gastroenterol. 2007; 42(6):497-500. DOI: 10.1007/s00535-007-2056-6. View

10.

Fukagawa M, Yumita S, Akizawa T, Uchida E, Tsukamoto Y, Iwasaki M . Cinacalcet (KRN1493) effectively decreases the serum intact PTH level with favorable control of the serum phosphorus and calcium levels in Japanese dialysis patients. Nephrol Dial Transplant. 2007; 23(1):328-35. DOI: 10.1093/ndt/gfm534. View

11.

Norton J, Venzon D, Berna M, Alexander H, Fraker D, Libutti S . Prospective study of surgery for primary hyperparathyroidism (HPT) in multiple endocrine neoplasia-type 1 and Zollinger-Ellison syndrome: long-term outcome of a more virulent form of HPT. Ann Surg. 2008; 247(3):501-10. PMC: 2717476. DOI: 10.1097/SLA.0b013e31815efda5. View

12.

Gregoire F, Pariente A, Fourrier-Reglat A, Haramburu F, Begaud B, Moore N . A signal of increased risk of hypoglycaemia with angiotensin receptor blockers caused by confounding. Br J Clin Pharmacol. 2008; 66(1):142-5. PMC: 2485248. DOI: 10.1111/j.1365-2125.2008.03176.x. View

13.

Nagano N, Kawata T, Wada M . [Pharmacological and clinical profiles of calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients on dialysis (cinacalcet hydrochloride, REGPARA)]. Nihon Yakurigaku Zasshi. 2008; 132(5):301-8. DOI: 10.1254/fpj.132.301. View

14.

Cryer P, Axelrod L, Grossman A, Heller S, Montori V, Seaquist E . Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2008; 94(3):709-28. DOI: 10.1210/jc.2008-1410. View

15.

Murad M, Coto-Yglesias F, Wang A, Sheidaee N, Mullan R, Elamin M . Clinical review: Drug-induced hypoglycemia: a systematic review. J Clin Endocrinol Metab. 2008; 94(3):741-5. DOI: 10.1210/jc.2008-1416. View

16.

Placzkowski K, Vella A, Thompson G, Grant C, Reading C, Charboneau J . Secular trends in the presentation and management of functioning insulinoma at the Mayo Clinic, 1987-2007. J Clin Endocrinol Metab. 2009; 94(4):1069-73. DOI: 10.1210/jc.2008-2031. View

17.

Kimura W, Kuroda A, Morioka Y . Clinical pathology of endocrine tumors of the pancreas. Analysis of autopsy cases. Dig Dis Sci. 1991; 36(7):933-42. DOI: 10.1007/BF01297144. View

18.

Hills C, Younis M, Bennett J, Siamantouras E, Liu K, Squires P . Calcium-sensing receptor activation increases cell-cell adhesion and β-cell function. Cell Physiol Biochem. 2012; 30(3):575-86. DOI: 10.1159/000341439. View

19.

Squires P, Jones P, Younis M, Hills C . The calcium-sensing receptor and β-cell function. Vitam Horm. 2014; 95:249-67. DOI: 10.1016/B978-0-12-800174-5.00010-7. View

20.

Meng K, Xu J, Zhang C, Zhang R, Yang H, Liao C . Calcium sensing receptor modulates extracellular calcium entry and proliferation via TRPC3/6 channels in cultured human mesangial cells. PLoS One. 2014; 9(6):e98777. PMC: 4048219. DOI: 10.1371/journal.pone.0098777. View